We are testing a new drug for individuals with familial polycythemia caused by an EPO gene mutation. The goal is to see if it is safe and effective in managing their condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Familial polycythemia associated with an EPO gene mutation is a rare genetic disorder that causes the body to produce too many red blood cells, which can lead to complications such as blood clots and increased blood viscosity.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.